2 recruiting, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 2, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Resistant Cancer: new trials by email Literature Review of Resistant Cancer trials Research Report on Resistant Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous CAR-T Cells Targeting B7-H3 in PDAC iC9-CAR.B7-H3 T cell infusion - Pancreas Cancer, Relapse | Phase 1 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 27 | 2024-07-18 | 2026-06-08 |
| Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells iC9-CAR.B7-H3 T Cell Therapy, cyclophosphamide, fludarabine - Breast Cancer, Relapse | Phase 1 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 42 | 2024-06-27 | 2026-07-28 |
| Lorlatinib Combinations in Lung Cancer Lorlatinib, Crizotinib, Binimetinib - Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation | Phase 1 / Phase 2 | Unknown | Massachusetts General Hospital | 96 | 2020-05-01 | 2021-03-10 |
Recurrence (3) · Breast Neoplasms (1) · Lung Neoplasms (1) · Pancreatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Disease Attributes (3) · Neoplasms (3) · Neoplasms by Site (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Breast Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Lung Diseases (1) · Pancreatic Diseases (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Skin Diseases (1)
Cell- and Tissue-Based Therapy (1) · Crizotinib (1) · Cyclophosphamide (1) · binimetinib (1) · fludarabine (1) · fludarabine phosphate (1) · lorlatinib (1)
UNC Lineberger Comprehensive Cancer Center (2) · Massachusetts General Hospital (1)
United States (3)
Ashwin Somasundaram, MD (1) · Ibiayi Dagogo-Jack, MD (1) · Yara Abdou, MD (1)
P50CA058223 (1)